Sattva Sukun Lifecare Limited (formerly Mayukh Dealtrade Limited) has informed BSE Limited that its board meeting scheduled for February 14, 2026, could not be conducted due to the absence of requisite quorum. The meeting was convened to consider and approve unaudited financial results for the quarter ended December 31, 2025.

Meeting Postponement Details

The company has submitted a clarification to BSE Limited under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, explaining the delay in filing Q3FY26 financial results. As the required quorum was not present, the meeting stood adjourned in accordance with the provisions of the Companies Act, 2013.

Impact on Financial Results

Consequently, the approval and submission of the unaudited financial results have been delayed. The company has assured that the adjourned board meeting will be convened on Monday, February 16, 2026, and the unaudited financial results shall be considered and submitted to the exchange immediately thereafter within the prescribed time.

Original Meeting Agenda

Regulatory Compliance

The company remains committed to statutory compliance and timely disclosures in accordance with SEBI regulations. Company Secretary Poonam Rani has digitally signed the official communication to BSE Limited, requesting the exchange to take the explanation on record.

Company Information

The trading window restrictions that were implemented from January 01, 2026, for designated persons and their immediate relatives under SEBI insider trading regulations remain in effect until 48 hours after the conclusion of the rescheduled board meeting.

Sattva Sukun Lifecare Limited , formerly known as Mayukh Dealtrade Limited, has reported a delay in filing its financial results for the quarter and half-year ended September 30, 2025. The company attributes this delay to the recent acquisition of a subsidiary, Pavapuri Export Private Limited, during the reporting period.

Reasons for Delay

The company cited several factors contributing to the postponement:

1. Subsidiary Acquisition: The acquisition of Pavapuri Export Private Limited necessitated the preparation of consolidated financial statements.
2. Integration Process: The following steps were required for proper integration:
   • Verification and alignment of accounting policies and reporting frameworks
   • Preparation and validation of consolidated accounts
   • Review of financial data and reconciliations
   • Finalization of consolidated financial statements

Timeline of Events

Company's Statement

In a clarification to the BSE Limited, Sattva Sukun Lifecare emphasized that the delay was unintentional and solely due to procedural and consolidation requirements arising from the new subsidiary acquisition. The company stated that it remains committed to statutory compliance and timely disclosures in accordance with SEBI regulations.

Impact and Compliance

While the delay in filing financial results is a deviation from the standard reporting timeline set by SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has taken steps to address the issue:

1. Provided a detailed explanation to the stock exchange
2. Submitted the financial results along with the Limited Review Report post-approval

Investors and stakeholders should note that such delays, while not ideal, can occur during significant corporate actions like acquisitions. The company's transparency in explaining the delay and its commitment to regulatory compliance are positive signs for maintaining investor trust.

As the financial data is not readily available, investors are advised to review the complete financial results once they are publicly disclosed to assess the company's performance and the impact of the new subsidiary on its financials.